Company Directory > CRO > NSABP Foundation
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of NSABP Foundation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
The NSABP Foundation is a prominent, non-profit academic research organization dedicated to designing and conducting practice-changing clinical trials in breast and colorectal cancers. With a history spanning over 60 years, the organization has pioneered standards of care, including the transition from radical mastectomy to lumpectomy plus radiation, and the use of adjuvant therapy to improve survival rates. Headquartered in Pittsburgh, Pennsylvania, the Foundation manages a vast network of over 700 clinical research sites across the United States, Canada, Puerto Rico, and Ireland. It is a key component of NRG Oncology, a non-profit corporation that integrates the research of the legacy NSABP, Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs to advance cancer treatment and prevention.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Oncology clinical research
SIZE & FINANCIALS
Employees:51-200
Founded:1958
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Phase 3
Lead Drug Stage:Clinical Trials (Phase III)
Modalities:Small molecule, mAb
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:NRG Oncology (Integrated research network), National Cancer Institute (NCI) (Primary funding/support), Exact Sciences (Clinical validation studies)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Priya Rastogi - Chief Executive Officer
Norman Wolmark - Chairman
Charles Geyer, Jr. - Chief Scientific Officer
LINKS
Website:nsabp.org
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NSABP Foundation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.